Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Matrix Laboratories, a subsidiary of Mylan, has obtained the US Food and Drug Administration's (FDA) final approval for its abbreviated new drug application (ANDA) of Donepezil Hydrochloride (HCl) Tablets, 5 mg and 10 mg.
Subscribe to our email newsletter
Matrix‘s Donepezil Hydrochloride (HCl) Tablets, 5mg and 10mg are the generic version of Aricept Tablets of Eisai.
Aricept is a prescription medicine which is indicated for the treatment of dementia linked with mild, moderate, and severe Alzheimer’s disease.
Aricept improves the function of nerve cells in the brain and works by preventing the breakdown of a chemical called acetylcholine.